Eye-Interaction Pioneer Eyefluence Announces Company Launch, Series B Funding

Comments are closed.

H2U Technologies extends series A financing and expands board of directors
Envisagenics Raises Series A Financing to Scale Its AI-powered RNA Splicing Drug Discovery Platform
Triple Blind Expands Board of Directors
Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration